Pharmacotherapy of Bipolar Disorders

1. Auflage 2007
ISBN: 978-0-470-05823-7
Verlag: Wiley & Sons

Buch, Englisch, 296 Seiten, Format (B × H): 174 mm x 244 mm, Gewicht: 704 g

Lieferung vom Verlag mit leichten Qualitätsmängeln möglich

Autoren/Hrsg.

Schaad, Nicolas

Aubry, Jean-Michel

Ferrero, Francois

Bauer, Mark

Weitere Mitwirkende

Bauer, Mark

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakotherapie, Psychopharmakotherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie

Inhaltsverzeichnis

Foreword.

Preface by N. Sartorius.

Chapter 1 Epidemiology of bipolar disorders.

Chapter 2 Classification of bipolar disorders.

Chapter 3 How to define a mood stabilizer.

Chapter 4 Lithium.

Chapter 5 Carbamazepine.

Chapter 6 Lamotrigine.

Chapter 7 Topiramate.

Chapter 8 Valproic acid.

Chapter 9 The role of atypical or second generation antipsychotics.

Chapter 10 Other medications used for bipolar disorders.

Chapter 11 Medications that may potentially induce a depressive state.

Chapter 12 Medications that may potentially induce a (hypo)manic syndrome.

Chapter 13 Maintenance treatment: when should be a long term treatment introduced.

Chapter 14 Treatment of the depressive phases of bipolar disorders.

Chapter 15 Treatment of Bipolar II disorder.

Chapter 16 Treatment of manic phases.

Chapter 17 Treatment of rapid cycling.

Chapter 18 Treatment of mixed states.

Chapter 19 Combination treatments.

Chapter 20 Bipolar disorders, pregnancy and breastfeeding.

Chapter 21 Bipolar disorders in children and adolescents.

Chapter 22 Bipolar disorders in geriatric patients.

Appendix.

1. Diagnostic criteria ICM 10.

2. Diagnostic criteria DSM IV.

3. FDA approved medications for the treatment of bipolar disorders.

4. Major guidelines for bipolar disorders.

5. Trade names of selected drugs used in bipolar disorders.

List of abbreviations.

Index.

Über Autor(innen)

Jean-Michel Aubry is a psychiatrist and psychotherapist. He is privat docent at the Medical School of the University of Geneva where he teaches Neurosciences and Psychiatry. As head of a specialised programme for bipolar disorders at the Department of Psychiatry of the Geneva University Hospital, Dr Aubry's research interests include the pharmacologicala and psychosocial treatments of bipolar disorders and more specifically, relapse prevention.


François Ferrero is psychiatrist, psychotherapist, professor of psychiatry and chair of the Department of Psychiatry of the University of Geneva. His research in the domain of bipolar disorders aims to better specify the epidemiology and the links with genetics and the environment in order to develop and evaluate ever more effective therapeutic and preventive approaches.


Nicolas Schaad is the pharmacist in charge of the pharmacy la Côte that serves the hospital network of the Geneva-Lausanne region. Within this structure, he has developed a clinical pharmacy service. He is privat docent in the pharmacy section, and he also teaches in the Department of Fundamental Neurosciences at the University of Geneva. For the past few years, his research interests have been oriented towards a psychopharmacology applied to psychiatric disorders.



Mark S. Bauer is Professor in the Department of Psychiatry and Human Behavior at Brown University and on staff in the Mental Health service of the Department of Veterans Affairs Medical Center in Providence, Rhode Island, USA. He has been recognized with awards for his research, clinical expertise and teaching skills. He served for 11 years on the Scientific Advisory Board for the Depression and Bipolar Support Alliance and has been named Exemplary Psychiatrist by the National Alliance for the Mentally Ill.